Response to 'renal injury in extreme obesity: The important role of aldosterone'

Kidney International

Volumn 74, Issue 9, 2008, Pages 1216-1217

  Serra, Assumpta ^a   Romero, Ramón ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCORTISONE; LEPTIN; RENIN; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BARIATRIC SURGERY; BODY MASS; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; GLOMERULOSCLEROSIS; HORMONE BLOOD LEVEL; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; LETTER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

EID: 53949092384     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.438     Document Type: Letter

References (11)

1. Bomback A, Klemmer P. Renal injury in extreme obesity: the important role of aldosterone. Kidney Int 2008; 74: 1216.
2. Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity. Endocr Res 1998; 24: 789-796.
3. Serra A, Granada ML, Romero R et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr 2006; 25: 400-408.
4. Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999; 56: 860-872.
5. Rocha R, Stier CT, Kifor I et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000; 141: 3871-3878.
6. Rocha R, Chander PN, Zuckerman A et al. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 1999; 33: 232-237.
7. Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996; 98: 1063-1068.
8. Bomback AS, Kshirsagar AV, Amamoo A et al. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a sistematic review. Am J Kidney Dis 2008; 51: 199-211.
9. Serra A, Romero R, Lopez D et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008; 73: 947-955.
10. Praga M, Hérnandez E, Andrés A et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995; 70: 35-41.
11. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28.